Found: 74
Select item for more details and to access through your institution.
Association between glucagon‐like peptide‐1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5183, doi. 10.1111/dom.15864
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4811, doi. 10.1111/dom.15136
- Publication type:
- Article
Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID‐19: Up to 40 months' follow‐up.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5368, doi. 10.1111/dom.15900
- By:
- Publication type:
- Article
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5202, doi. 10.1111/dom.15866
- By:
- Publication type:
- Article
The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5455, doi. 10.1111/dom.15924
- By:
- Publication type:
- Article
Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5444, doi. 10.1111/dom.15923
- By:
- Publication type:
- Article
Ultra‐processed foods cause weight gain and increased energy intake associated with reduced chewing frequency: A randomized, open‐label, crossover study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5431, doi. 10.1111/dom.15922
- By:
- Publication type:
- Article
Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5420, doi. 10.1111/dom.15918
- By:
- Publication type:
- Article
Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5358, doi. 10.1111/dom.15899
- By:
- Publication type:
- Article
Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5408, doi. 10.1111/dom.15917
- By:
- Publication type:
- Article
Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5013, doi. 10.1111/dom.15915
- By:
- Publication type:
- Article
Prevalence of complications and co‐morbidities in males and females with obesity: Real‐world insights from claims data analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5005, doi. 10.1111/dom.15914
- By:
- Publication type:
- Article
Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose‐lowering therapies.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4996, doi. 10.1111/dom.15912
- By:
- Publication type:
- Article
Semaglutide use in people with obesity and type 2 diabetes from real‐world utilization data: An analysis of the All of US Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4989, doi. 10.1111/dom.15911
- By:
- Publication type:
- Article
Birthweight influences liver structure, function and disease risk: Evidence of a causal association.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4976, doi. 10.1111/dom.15910
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors: Writing the next chapter of a unique success story.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5399, doi. 10.1111/dom.15908
- By:
- Publication type:
- Article
Glucose‐lowering medicines use before and after entry into long‐term care facilities.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4966, doi. 10.1111/dom.15905
- By:
- Publication type:
- Article
Glycaemic treatment of newly diagnosed type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5492, doi. 10.1111/dom.15904
- By:
- Publication type:
- Article
The effectiveness and sustainability of health outcomes from a holistic digital weight‐loss service with concomitant initiation of tirzepatide: A pragmatic randomized controlled trial in the UK.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4854, doi. 10.1111/dom.15903
- By:
- Publication type:
- Article
Reduced insulin clearance in paediatric metabolic (dysfunction)‐associated fatty liver disease and its dual role in beta‐cell offload and diabetes risk.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5390, doi. 10.1111/dom.15902
- By:
- Publication type:
- Article
A meta‐analysis of randomized controlled studies examining the effects of sodium‐glucose co‐transporter‐2 inhibitors on peripheral artery disease and risk of amputations.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5376, doi. 10.1111/dom.15901
- By:
- Publication type:
- Article
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4958, doi. 10.1111/dom.15898
- By:
- Publication type:
- Article
Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895
- By:
- Publication type:
- Article
[P<sup>3</sup>]PP, a stable, long‐acting pancreatic polypeptide analogue, evokes weight lowering and pancreatic beta‐cell‐protective effects in obesity‐associated diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4945, doi. 10.1111/dom.15897
- By:
- Publication type:
- Article
Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5347, doi. 10.1111/dom.15896
- By:
- Publication type:
- Article
Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4813, doi. 10.1111/dom.15892
- By:
- Publication type:
- Article
Prognostic value of the stress‐hyperglycaemia ratio in patients with moderate‐to‐severe coronary artery calcification: Insights from a large cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4933, doi. 10.1111/dom.15894
- By:
- Publication type:
- Article
Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4924, doi. 10.1111/dom.15893
- By:
- Publication type:
- Article
Performance of the MiniMed 780G system on mitigating menstrual cycle‐dependent glycaemic variability.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4916, doi. 10.1111/dom.15891
- By:
- Publication type:
- Article
The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5466, doi. 10.1111/dom.15862
- By:
- Publication type:
- Article
Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5325, doi. 10.1111/dom.15890
- By:
- Publication type:
- Article
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4905, doi. 10.1111/dom.15889
- By:
- Publication type:
- Article
Impact of baseline characteristics on the efficacy of once‐weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5312, doi. 10.1111/dom.15888
- By:
- Publication type:
- Article
Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J‐mono and J‐combo studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5304, doi. 10.1111/dom.15887
- By:
- Publication type:
- Article
Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT‐ONE.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4897, doi. 10.1111/dom.15886
- By:
- Publication type:
- Article
Use of real‐time continuous glucose monitoring in non‐critical care insulin‐treated inpatients under non‐diabetes speciality teams in hospital: A pilot randomized controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5483, doi. 10.1111/dom.15885
- By:
- Publication type:
- Article
The association of type 2 diabetes‐related characteristics with fracture risk at different sites.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4887, doi. 10.1111/dom.15884
- By:
- Publication type:
- Article
A cohort analysis of familial partial lipodystrophy from two Mediterranean countries.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4875, doi. 10.1111/dom.15882
- By:
- Publication type:
- Article
Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5293, doi. 10.1111/dom.15881
- By:
- Publication type:
- Article
Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5283, doi. 10.1111/dom.15880
- By:
- Publication type:
- Article
Nicotinamide N‐methyltransferase inhibition mitigates obesity‐related metabolic dysfunction.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5272, doi. 10.1111/dom.15879
- By:
- Publication type:
- Article
Updating and calibrating the Real‐World Progression In Diabetes (RAPIDS) model in a non‐Veterans Affairs population.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5261, doi. 10.1111/dom.15878
- By:
- Publication type:
- Article
The prognostic role of cardiopulmonary exercise testing in obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5251, doi. 10.1111/dom.15877
- By:
- Publication type:
- Article
Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register‐based drug utilization study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5479, doi. 10.1111/dom.15876
- By:
- Publication type:
- Article
A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5474, doi. 10.1111/dom.15875
- By:
- Publication type:
- Article
Degree of joint risk factor control and incident chronic kidney disease among individuals with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4864, doi. 10.1111/dom.15874
- By:
- Publication type:
- Article
Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost‐effectiveness analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5470, doi. 10.1111/dom.15873
- By:
- Publication type:
- Article
Adherence to glucagon‐like peptide‐1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5239, doi. 10.1111/dom.15872
- By:
- Publication type:
- Article
The effectiveness of telemonitoring and integrated personalized diabetes management in people with insulin‐treated type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5233, doi. 10.1111/dom.15870
- By:
- Publication type:
- Article